A phase I study of the anti-insulin like growth factor type 1 receptor (IGF-1R) antibody dalotuzumab in pediatric patients with advanced solid tumors

被引：0

作者：

Frappaz, Didier

McGregor, Lisa M.

Pearson, Andrew Dj

Gore, Lia

DuBois, Steven G.

Aerts, Isabelle

Iannone, Robert

Geschwindt, Ryan

Van Schanke, Arne

Wang, Ruixue

Geoerger, Birgit

机构：

[1] Inst Hematol & Oncol Pediat, Lyon, France

[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA

[3] Inst Canc Res, Sutton, Surrey, England

[4] Royal Marsden Hosp, Sutton, Surrey, England

[5] Univ Colorado Denver, Div Med Oncol, Aurora, CO USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Inst Curie, Paris, France

[8] Merck, N Wales, PA USA

[9] Inst Gustave Roussy, Villejuif, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10026

引用

页数：1